|
|
Volumn 3, Issue 3, 2006, Pages 277-278
|
|
Race/ethnicity, lipoproteins, and antiretroviral therapy
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRETROVIRUS AGENT;
APOLIPOPROTEIN A1;
APOLIPOPROTEIN C3;
PROTEINASE INHIBITOR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
CARDIOVASCULAR RISK;
CLINICAL TRIAL;
DYSLIPIDEMIA;
ENZYME ACTIVITY;
ETHNOLOGY;
GENETIC VARIABILITY;
GENOTYPE;
HAPLOTYPE;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
PROTEIN BLOOD LEVEL;
RACE DIFFERENCE;
SHORT SURVEY;
SINGLE NUCLEOTIDE POLYMORPHISM;
|
|
EID: 33645355400
PISSN: 15491277
EISSN: 15491676
Source Type: Journal
DOI: 10.1371/journal.pmed.0030098 Document Type: Short Survey |
|
Times cited : (3)
|
|
References (1)
|
